FDA Warns Quasar For Lack Of Proper Skin-Care Device Clearance; Firm Cites Mix-Up
This article was originally published in The Rose Sheet
Executive Summary
An FDA warning letter to Quasar Bio-Tech suggests the marketer of Baby Quasar and Quasar MD lacks correct 510(k) device clearance and is improperly marketing its home-use skin-care device products. Quasar maintains it holds the correct clearances, and that FDA may be confused by its product nomenclature.
You may also be interested in...
LightStim Device For “Full-Face Wrinkles” Generates Acquisition Interest
LED Intellectual Properties’ receipt of 510(k) clearance for its LightStim device, designed to treat “full-face wrinkles,” has not gone unnoticed by personal-care firms looking to enter or grow their stake in the burgeoning aesthetic device market.
Research In Brief
Researchers link blue-light skin-treatment devices, increasingly being implemented in professional settings and used by consumers at home, to vision problems. Chitosan microparticles show promise as delivery mechanism for green tea extract, the antioxidant benefit of which is typically limited due to poor skin penetration. More research in brief.
In Brief
Skin-Care Devices Are Next $1 Bil. Market